This article is part of a themed issue Therapeutic Targeting of G Protein-Coupled Receptors: hot topics from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists 2021 Virtual Annual Scientific Meeting. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v181.14/issuetoc.
Keywords: G protein; G protein‐coupled receptors (GPCRs); PROTAC; allostery; artificial intelligence; cardiometabolic; cardiovascular; disease mechanisms; effectors; epilepsy; fibrosis; orphan; phosphoproteomics; regulation; schizophrenia; second messengers.
© 2024 British Pharmacological Society.